Latest news
Calls, articles and moreMeet three new partners
Earlier this year, the DCVA gained three valuable partners. Learn what these three parties stand for, how they are valuable to the DCVA, and how the DCVA is valuable to them.
![3partners 16x9 400]()
Start of the DCVA Leadership Program 2020
The first edition of the DCVA Leadership Program officially started. During three days of training and social interaction Margreet van Rixtel trained the fifteen participants in taking their first steps of becoming leaders who are able to solve complex current healthcare related problems.
![10]()
DCVA COVID-19 update
Are COVID-19 patients at increased risk to develop ischemic stroke and what are the first results of CAPACITY? In this update, we present the new COVID-19 project STROCORONA and the first results of CAPACITY.
![Stock-1863880_1920b]()
New implementation consortium CUSTOM-AF
Preventing cerebral infarctions caused by atrial fibrillation. That is the main goal of the implementation consortium CUSTOM-AF.
![AF]()
Meet the partners
A double interviewIn this sixth and final edition of Meet the partners, we interview leaders of two of these partners, namely Floris Italianer (left), CEO of the Dutch Heart Foundation and prof. dr. Arno Hoes (right), dean of the Faculty of Medicine of the UMC Utrecht and formal prepresentative of the NFU.
![Meet the partners 16x9 400]()
4th Translational Cardiovascular Research Meeting
Although the setup was a little different than that of the former three editions, the congress was again well received.
![Laptop 16x9 300]()
Join Y@H or become a mentor
To strengthen our cardiovascular talent community, we invite PhD students and post-docs to actively participate in Young@Heart activities.
![Youngatheart1]()
Help us review the EU blueprint
The ESC and the EHN have launched a blueprint for EU action against cardiovascular disease. We invite researchers and leaders in the field to read the this document and share your insights.
![Blueprint 16x9 300]()
Hospitals sought for Valsartan study
Can Valsartan prevent serious accumulation of fluid in the lungs in COVID-19? To answer this question, the Dutch Cardiovascular Alliance started the Praetorian COVID study. Initiators and research leaders Niels van Royen and Roland van Kimmenade (Radboudumc) are urging colleagues from other hospitals to participate.
![Valsartan-16x9-600]()
COVID-19 research: avoid duplication
Register your COVID studiesAvoid duplication, combine efforts, maximise results, register your COVID-studies now
![Register-16x9small]()
DCVA supports studies
Given the strong correlation and potentially deadly entanglement of COVID-19 and cardiovascular diseases, the DCVA decided to support two research studies
![Stock-1863880_1920b]()
Strategy meeting
First digital DCVA strategy meeting to identify future opportunitiesHow nephrology and cardiology share common goals, what COVID-19 teaches us about working together with fifteen partners, three dilemmas and no socialising during drinks and dinner: those were the highlights of our first online but vivid strategy meeting on 1 April.
![Away-day-16x9-small]()
Meet the partners
A double interviewIn this fifth edition of Meet the partners we interview Niek Dubelaar LLM MSc (left), Head of Knowledge Transfer Office of KNAW and Dr. ir. Herry Nijhuis (right), Director NWO Applied and Engineering Sciences (TTW).
![Samengesteld-KNAW-enn-NWO-16x9-small]()
CAPACITY COVID REGISTRY
COVID-19 patients with cardiovascular disease are an extremely vulnerable population. To give these patients the best possible care and to be prepared for future outbreaks, we need to know more about these patients and the best practices for treating them. Therefore DCVA partners launched the CAPACITY COVID Registry.
![Capacitylogo16x9small]()
DCVA & RegMedXB fund launched
Launch of fund to accelerate development of solutions for prevention and cure of chronic diseases ensuring patients benefit earlier
![DCVA-x-REGMEDxb-b]()
Lukas Dekker
Interview with the first DCVA AmbassadorThere is much to be achieved with technology in the area of prevention, earlier detection and better treatment. The brand new professor Lukas Dekker wants to be the first DCVA ambassador to build bridges between cardiologists and technologists.
![Lucas-dekker-16x9]()
Start of the Leadership Program
Fifteen future leaders selectedRecently a group of talents has been selected as the future leaders in the cardiovascular arena. They are subject of the first edition of the DCVA Leadership Program.
![Leadership216x9-1600]()
Five million awarded to six projects in first DCVA call
In light of the first DCVA call ‘Heart for sustainable care’, six research teams received a total of over five million euros for research into the use of new technology against cardiovascular diseases.
![Hart-innovatie-technologie-digitaal-16x9]()
Centralisation Dutch figures on CV disease
Dutch Heart Foundation and Dutch Heart Registration join forcesData on cardiovascular disease in the Netherlands can be found in various places. The DHF and NHR joined forces and launched their new website to centralise all these data
![Numbers16x9small]()
Intensification of cooperation DHF, NVVC, Harteraad in the context of the DCVA
Early detection of heart failure, atrial fibrillation and chest pain and the best treatment, tailored to patients' personal needs. To achieve this, the four partners will collaborate even more intensively in the coming three years
![Samenwerking-nvvc-harteraad-dcva-16x9]()
